To determine if CXCR4 and CCR7 heterodimerization are relevant to the development of human breast cancer, we took advantage of the proximity ligation assay (PLA), a well-established method for determining in situ protein-protein interactions [39] (Figure 3A). The gene discussed is CXCR4; the disease is breast cancer.